Triamterene And Hydrochlorothiazide Capsule
Product Images NDC 70771-1474

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Triamterene And Hydrochlorothiazide (NDC 70771-1474). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Dfaa6d55 C7c2 4ab0 9a48 90146c32f665 01)

FDA Label Image

Image (Dfaa6d55 C7c2 4ab0 9a48 90146c32f665 02)

FDA Label Image

Image (Dfaa6d55 C7c2 4ab0 9a48 90146c32f665 03)

Image (Dfaa6d55 C7c2 4ab0 9a48 90146c32f665 03)
NDC 7077114741 is a drug in capsule form containing Triamterene and Hydrochlorothiazide. The capsules are to be stored at room temperature and dispensed in a light-resistant container. The usual dosage is 1 or 2 capsules once daily. It is important to keep this and all drugs out of the reach of children. The drug is manufactured by Cadila Healthcare Ltd. in India.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.